Cargando…
Quantitative Analysis and Diagnostic Significance of Methylated SLC19A3 DNA in the Plasma of Breast and Gastric Cancer Patients
BACKGROUND: Previously, we have examined the methylation status of SLC19A3 (solute carrier family 19, member 3) promoter and found that SLC19A3 was epigenetically down-regulated in gastric cancer. Here, we aim to develop a new biomarker for cancer diagnosis using methylated SLC19A3 DNA in plasma. ME...
Autores principales: | Ng, Enders K. O., Leung, Candy P. H., Shin, Vivian Y., Wong, Chris L. P., Ma, Edmond S. K., Jin, Hong Chuan, Chu, Kent-Man, Kwong, Ava |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138782/ https://www.ncbi.nlm.nih.gov/pubmed/21789241 http://dx.doi.org/10.1371/journal.pone.0022233 |
Ejemplares similares
-
Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer
por: Ng, Enders K, et al.
Publicado: (2014) -
A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer
por: Shin, Vivian Yvonne, et al.
Publicado: (2015) -
MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer
por: Shin, Vivian Yvonne, et al.
Publicado: (2018) -
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
por: Ng, Enders K. O., et al.
Publicado: (2013) -
MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer
por: Ng, Enders K. O., et al.
Publicado: (2009)